MODERATOR
:
SPEAKER
(S):
Paul M. Ness, MD, Director, Transfusion Medicine, Johns Hopkins Hospital
Transfusion in the face of known incompatability,, Reversing warfarin anticoagulation - what should we give?
Walter Dzik, MD, Co-Director, Blood Transfusion Service, MGH, Boston, Mass General Hospital
reversing warfaring anticoagulation - what should we give?,
Dr. Dan Waxman, MD, Executive Vice President/Chief Medical Officer, Indiana Blood Center
Neonatal cardiac surgery - blood product selection and transfusion support
Mark Fung, MD, PhD, Medical Director, Blood Bank and Transfusion Services, Fletcher Allen Health Care/ Univ. of Vermont
Out of Group platelet transfusions - hazards of passive anti-A and anti-B
Description
In this interactive case study-based session, physician attendees will participate and share their own responses with the faculty experts and other audience members. The session will focus on several timely issues in current practice and attendees will gain an appreciation of the range of medical decision-making for these topics.
LEARNER OUTCOMES:
-
Describe the hazards of ABO incompatible platelet transfusions, the role of isoagglutinin titers and other interventions.
-
Examine the debate over blood product selection for neonatal cardiac surgery.
-
Explain clinical and serologic issues to help physicians know when to begin and continue transfusion therapy for patients with autoimmune hemolytic anemia.
-
Recognize the range of options available to reverse pharmacologic anticoagulation in urgent care patients.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.